Skip to content

Rehabilitation in Multiple Sclerosis: Influence of Exercise on Development of Insulin Resistance, Muscle Power and Aerobic Capacity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01718392
Enrollment
45
Registered
2012-10-31
Start date
2011-03-31
Completion date
2013-09-30
Last updated
2016-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

combined training, insulin resistance

Brief summary

the purpose of this study is to investigate the development of insulin resistance in multiple sclerosis patients + explaining the effects of a combined training programme on insulin resistance, muscle power and aerobic capacity in multiple sclerosis patients

Interventions

BEHAVIORALTraining

Sponsors

Hasselt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed MS according to the McDonald criteria * Expanded Disability Status Scale (EDSS) between 0.5 and 6 * Be able to train 5 times in 2 weeks at the University

Exclusion criteria

* Comorbidities like cardiovascular-, respiratory-, orthopaedic or metabolic diseases (like diabetes type 2) * Having had an relapse in a period of 3 months prior to the start of the intervention period * Having an relapse during the intervention period * Pregnancy and other contra indications for physical activity * Mental disorders

Design outcomes

Primary

MeasureTime frameDescription
insulin sensitivity (insulin profile)change from baseline to 24 weeksglucose and insulin concentration measurements in blood

Secondary

MeasureTime frameDescription
aerobic capacity - lactate concentrationschange from baseline to 24 weeksby means of a submaximal endurance test (ergometer) to determine lactate concentrations (mmol/L)
cytokine profilechange from baseline to 24 weeksmeasurements of blood cytokine levels
walking performancechange from baseline to 24 weeksWalking performance will be assessed by means of 2 and 6 minute walk test, 25-foot walk test, Chair rise test, Stair climb test
Self-reported measuresChange from baseline to 24 weeksThe self-reported measures contains some questionnaires
aerobic capacitychange from baseline to 24 weeksby means of a submaximal endurance test (ergometer)
muscle strength of knee flexorchange from baseline to 24 weeksby means of an isokinetic dynamometer the muscle strength and endurance will be measured
muscle strength of knee extensorchange from baseline to 24 weeksby means of an isokinetic dynamometer the muscle strength and endurance will be measured
muscle strength of elbow flexorchange from baseline to 24 weeksby means of an isokinetic dynamometer the muscle strength will be measured
muscle strength of elbow extensorchange from baseline to 24 weeksby means of an isokinetic dynamometer the muscle strength will be measured
body compositionChange from baseline to 24 weeksWeight, body fat% and lean tissue% will be assessed by means of a DEXA (Dual-energy X-ray absorptiometry) scan

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026